Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury.
Subject: Heart Disease - PUBLISHED VIA American Journal of Physiology
Author(s):
Durst R, Danenberg H, Gallily R, Mechoulam R, Meir K, Grad E, Beeri R, Pugatsch T, Tarsish E, Lotan C
View Source >>
Related Studies:
Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy.
Published via Author Manuscript
The effect of cannabidiol on ischemia/reperfusion-induced ventricular arrhythmias: the role of adenosine A1 receptors.
Published via Journal of Cardiovascular Pharmacology and Therapeutics
Cannabidiol as an anti-arrhythmic, the role of the CB1 receptors
Published via BMJ Publishing Group Limited
Is the cardiovascular system a therapeutic target for cannabidiol?
Published via British Pharmacological Society
Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion.
Published via British Journal of Pharmacology